| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $275K | +175.7% |
| R&D Expense | $163K | -85.5% |
| SG&A Expense | $8.9M | -53.9% |
| Operating Income | -$12.6M | +65.4% |
| Pre-tax Income | -$8.6M | +74.4% |
| Net Income | -$8.6M | +74.4% |
| EPS (Basic) | -$1.97 | -93.1% |
| EPS (Diluted) | -$1.97 | -93.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $172K | +15.3% |
| Accounts Receivable | $250K | +709.8% |
| Current Assets | $1.6M | +33.5% |
| Total Assets | $15.3M | -15.7% |
| Current Liabilities | $10.8M | -24.1% |
| Total Liabilities | $11.8M | -23.6% |
| Stockholders' Equity | $3.5M | +30.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | +63.8% |
| Capital Expenditures | $24K | -55.7% |
| Investing Cash Flow | -$24K | +91.6% |
| Financing Cash Flow | $5.1M | -59.9% |
| Free Cash Flow | -$5.1M | +63.7% |